Abiopharma

News list

Director Eltoukhy Helmy 🟡 adjusted position in 30.0K shares of Guardant Health, Inc. (GH) Transaction Date: Aug 26, 2026 | Filing ID: 000016

Full text

News bot Aug. 27, 2026, 11:47 p.m.
🔍 Eltoukhy Helmy (Director)

Company: Guardant Health, Inc. (GH)

Report Date: 2026-08-26
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 25,000
- Total shares sold: 55,000
Detailed Transactions and Holdings:
- Sold 25,000 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: J | equity_swap_involved: 0 | shares_owned_after: 1,970,934.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 25,000 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: J | equity_swap_involved: 0 | shares_owned_after: 60,000.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 30,000 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: G | equity_swap_involved: 0 | shares_owned_after: 1,940,934.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Reflects changes in form of ownership from Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation.
- F2: Reflects a gift of shares to a Donor Advisory Fund at Vanguard.